Wrapped tablets dichlororeytadin and its preparing method

A technology of desloratadine and coated tablets, which is applied in the field of pharmaceutical compositions and its preparation, can solve the problems of desloratadine being unstable when exposed to oxygen, moisture, and degraded by oxygen, and achieves solutions to moisture degradation, Improved stability, reduced handler effects

Inactive Publication Date: 2007-10-03
SHENZHEN SALUBRIS PHARMA CO LTD
View PDF11 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology uses less expensive ingredient(s) than traditional methods like adding water or other liquids during manufacturing process instead of relying solely upon dry processes such as evaporation techniques. It achieves this by reducing exposure time and temperature variations caused by these factors while maintaining consistency between different batches. Overall, this new approach simplifies the formulation process and makes medicine more stable over longer periods without excessive cost.

Problems solved by technology

This patented technical solution describes different ways to stabilize certain drugs like desloratinibodies called desmodilibrated cycloheptabonazepane(CAS). These techniques aim at reducing unwanted side effects caused by excessive absorption of carbohydrate ingredient complexions present within tissues during treatment procedures. They involve combining them together without changing their chemical structures, resulting in improved stability over time. Additionally, there may exist variations among forms of the same molecules when combined, leading to reduced decomposition rates and increased productivity compared to pure lyserdinapine. Overall, each technique helps maintain consistency and purity levels throughout the manufacturing procedure.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Wrapped tablets dichlororeytadin and its preparing method
  • Wrapped tablets dichlororeytadin and its preparing method
  • Wrapped tablets dichlororeytadin and its preparing method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039]1) At a temperature below 20°C, after grinding and mixing 5g of desloratadine, 20g of β-cyclodextrin and 15.6g of PEG4000 through a ball mill, the resulting mixture was granulated and pulverized with a 1.0mm screen of a rapid granulator to obtain granules;

[0040] 2) Mix the granules obtained in operation 1) with 53g of mannitol, 23g of low-substituted hydroxypropyl cellulose, 10.2g of calcium sulfate dihydrate and 4.56g of leucine, and then press it to obtain a tablet core. The hardness of the tablet is controlled at 3.2 kg / cm2 to 4.5kg / cm2;

[0041] 3) Mix 49.9g of hydroxyethyl cellulose, 6.51g of stearic acid and 29.3g of PEG6000 evenly to obtain a coating material;

[0042] 4) Take the coating material (accounting for 3% of the total tablet weight) and fill it on the die of the tablet press, then add the tablet core, then fill the coating material (accounting for 3% of the total tablet weight) on the upper layer of the tablet core, and press the tablet Deslo...

Embodiment 2

[0045] 1) At a temperature below 20°C, 5g of desloratadine, 7.3g of β-cyclodextrin and 7g of PEG4000 are mixed uniformly by a ball mill, and the resulting mixture is granulated and crushed with a 1.0mm sieve of a rapid granulator to obtain granules;

[0046] 2) Mix the granules obtained in operation 1) with 21.8g of mannitol, 10.6g of low-substituted hydroxypropyl cellulose, 5.4g of calcium sulfate dihydrate and 3g of leucine, and then compress to obtain a tablet core, and control the hardness of the tablet at 3.2kg / cm2 to 4.5kg / cm2;

[0047] 3) Mix 20g of hydroxyethyl cellulose, 2g of stearic acid and 17.9g of PEG6000 evenly to obtain a coating material;

[0048] 4) Take the coating material (accounting for 3% of the total tablet weight) and fill it on the die of the tablet press, then add the tablet core, then fill the coating material (accounting for 3% of the total tablet weight) on the upper layer of the tablet core, and press the tablet Desloratadine coated table...

Embodiment 3

[0051] 1) At a temperature below 20°C, after grinding and mixing 5g of desloratadine, 15.36g of β-cyclodextrin and 16.36g of PEG6000 by a ball mill, the resulting mixture was granulated and pulverized with a 1.0mm screen of a rapid granulator to obtain granules;

[0052] 2) Mix the granules obtained in operation 1) with 35.24g of mannitol, 13.19g of low-substituted hydroxypropyl cellulose, 10.81g of calcium sulfate dihydrate and 4.18g of leucine, and then press it into a tablet core to control the hardness of the tablet At 3.2kg / cm2 to 4.5kg / cm2;

[0053] 3) Mix 37.66g of hydroxyethyl cellulose, 1.67g of stearic acid and 29.23g of PEG6000 evenly to obtain a coating material;

[0054] 4) Take the coating material (accounting for 3% of the total tablet weight) and fill it on the die of the tablet press, then add the tablet core, then fill the coating material (accounting for 3% of the total tablet weight) on the upper layer of the tablet core, and press the tablet Deslor...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Melting pointaaaaaaaaaa
Hardnessaaaaaaaaaa
Login to view more

Abstract

A coated Desloratadine tablet features that it contains beta-cyclodextrin and leucine for preventing its degradation in oxygen and moisture, resulting in high stability. Its preparing process is also disclosed.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner SHENZHEN SALUBRIS PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap